Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of quetiapine compared to placebo in
the treatment for a major depressive episode in patients with bipolar disorder after
receiving treatment for up to 8 weeks.